EUVIMEDEUVIMED entdecken
Crossref

Intraoperative confocal laser endomicroscopy: prospective in vivo feasibility study of a clinical-grade system for brain tumors

Irakliy Abramov, Marian T Park, Evgenii Belykh, Alexander B Dru, Yuan Xu, Timothy C Gooldy, Lea Scherschinski, S Harrison Farber, Andrew S Little, Randall W Porter, Kris A Smith, Michael T Lawton und 2 weitere

Journal of Neurosurgery · 01.03.2023 · 138 (3) · 587-597

DOI: 10.3171/2022.5.jns2282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurosurgery, erschienen am 01.03.2023. Verfasst von Irakliy Abramov und 13 weiteren Autor:innen. Beteiligte Einrichtung: 1The Loyal and Edith Davis Neurosurgical Research Laboratory, Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Me…. Hauptthemen laut MEDLINE: Brain Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE The authors evaluated the feasibility of using the first clinical-grade confocal laser endomicroscopy (CLE) system using fluorescein sodium for intraoperative in vivo imaging of brain tumors. METHODS A CLE system cleared by the FDA was used in 30 prospectively enrolled patients with 31 brain tumors (13 gliomas, 5 meningiomas, 6 other primary tumors, 3 metastases, and 4 reactive brain tissue). A neuropathologist classified CLE images as interpretable or noninterpretable. Images were compared with corresponding frozen and permanent histology sections, with image correlation to biopsy location using neuronavigation. The specificities and sensitivities of CLE images and frozen sections were calculated using permanent histological sections as the standard for comparison. A recently developed surgical telepathology software platform was used in 11 cases to provide real-time intraoperative consultation with a neuropathologist. RESULTS Overall, 10,713 CLE images from 335 regions of interest were acquired. The mean duration of the use of the CLE system was 7 minutes (range 3–18 minutes). Interpretable CLE images were obtained in all cases. The first interpretable image was acquired within a mean of 6 (SD 10) images and within the first 5 (SD 13) seconds of imaging; 4896 images (46%) were interpretable. Interpretable image acquisition was positively correlated with study progression, number of cases per surgeon, cumulative length of CLE time, and CLE time per case (p ≤ 0.01). The diagnostic accuracy, sensitivity, and specificity of CLE compared with frozen sections were 94%, 94%, and 100%, respectively, and the diagnostic accuracy, sensitivity, and specificity of CLE compared with permanent histological sections were 92%, 90%, and 94%, respectively. No difference was observed between lesion types for the time to first interpretable image (p = 0.35). Deeply located lesions were associated with a higher percentage of interpretable images than superficial lesions (p = 0.02). The study met the primary end points, confirming the safety and feasibility and acquisition of noninvasive digital biopsies in all cases. The study met the secondary end points for the duration of CLE use necessary to obtain interpretable images. A neuropathologist could interpret the CLE images in 29 (97%) of 30 cases. CONCLUSIONS The clinical-grade CLE system allows in vivo, intraoperative, high-resolution cellular visualization of tissue microstructure and identification of lesional tissue patterns in real time, without the need for tissue preparation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsHumansFeasibility StudiesProspective StudiesMicroscopy, ConfocalLasers

Stichwörter der Autor:innen

confocal laser endomicroscopyfluorescence-guided surgeryintraoperative diagnosisneuropathologyneurosurgeryoncologytelemedicine

Autor:innen und Institutionen

  • 1The Loyal and Edith Davis Neurosurgical Research Laboratory, Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix.
  • 2Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix.
  • 4Department of Neurosurgery, Rutgers New Jersey Medical School, Newark, New Jersey.
  • 3Department of Neuropathology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona; and.

Zitieren

APA

Abramov, I., Park, M. T., Belykh, E., Dru, A. B., Xu, Y., Gooldy, T. C., Scherschinski, L., Farber, S. H., Little, A. S., Porter, R. W., Smith, K. A., Lawton, M. T., Eschbacher, J. M., & Preul, M. C. (2023). Intraoperative confocal laser endomicroscopy: prospective in vivo feasibility study of a clinical-grade system for brain tumors. Journal of Neurosurgery, 138(3), 587-597. https://doi.org/10.3171/2022.5.jns2282

Vancouver

Abramov I, Park MT, Belykh E, Dru AB, Xu Y, Gooldy TC, et al. Intraoperative confocal laser endomicroscopy: prospective in vivo feasibility study of a clinical-grade system for brain tumors. Journal of Neurosurgery. 2023;138(3):587-597. doi:10.3171/2022.5.jns2282

BibTeX
@article{Abramov2023,
  author = {Abramov, Irakliy and Park, Marian T and Belykh, Evgenii and Dru, Alexander B and Xu, Yuan and Gooldy, Timothy C and Scherschinski, Lea and Farber, S Harrison and Little, Andrew S and Porter, Randall W and Smith, Kris A and Lawton, Michael T and Eschbacher, Jennifer M and Preul, Mark C},
  title = {Intraoperative confocal laser endomicroscopy: prospective in vivo feasibility study of a clinical-grade system for brain tumors},
  journal = {Journal of Neurosurgery},
  year = {2023},
  volume = {138},
  number = {3},
  pages = {587--597},
  doi = {10.3171/2022.5.jns2282}
}
Kostenlos starten →